Concordance of Abundance for Mutational <i>EGFR</i> and Co-Mutational <i>TP53</i> with Efficacy of <i>EGFR</i>-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer
The present study aimed to investigate the influence of the mutation abundance of the epidermal growth factor receptor (<i>EGFR</i>) and its co-mutation with <i>TP53</i> on the therapeutic efficacy of tyrosine kinase inhibitor (TKI) treatment in patients with metastatic lung...
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI AG
2023-09-01
|
| Edice: | Current Oncology |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/1718-7729/30/9/616 |